TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹4,747 Cr | ₹3,942 Cr | ₹3,303 Cr | ₹2,917 Cr | ₹2,806 Cr |
What is the latest Profit & Loss Account Balance ratio of TORRENT PHARMACEUTICALS ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹4,747 Cr |
| Mar2024 | ₹3,942 Cr |
| Mar2023 | ₹3,303 Cr |
| Mar2022 | ₹2,917 Cr |
| Mar2021 | ₹2,806 Cr |
How is Profit & Loss Account Balance of TORRENT PHARMACEUTICALS Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,747 Cr | 20.40 | |
| Mar2024 | ₹3,942 Cr | 19.35 | |
| Mar2023 | ₹3,303 Cr | 13.25 | |
| Mar2022 | ₹2,917 Cr | 3.93 | |
| Mar2021 | ₹2,806 Cr | - | |
Compare Profit & Loss Account Balance of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹143,407.2 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,753.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,032.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| CIPLA | ₹108,360.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,859.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
| MANKIND PHARMA | ₹83,688.0 Cr | -2.6% | -5.6% | -15% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -0.5% |
5.3% |
40.2% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses